Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03065179
Title Trial of SBRT in Combination With Nivolumab/Ipilimumab in RCC / Kidney Cancer Patients
Acronym RADVAX
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Texas Southwestern Medical Center
Indications
Therapies
Age Groups: adult | senior | child
Covered Countries USA


No variant requirements are available.